Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
Status:
Completed
Trial end date:
2018-08-17
Target enrollment:
Participant gender:
Summary
This clinical trial studies sirolimus in treating patients with solid tumors that are
metastatic or cannot be removed by surgery. Sirolimus may stop the growth of tumor cells by
blocking some of the enzymes needed for cell growth